Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
25 Aug 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761350
21 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250721458902/en/Samsung-Bioepis-Releases-Third-Quarter-2025-US-Biosimilar-Market-Report-Exploring-the-Most-Favored-Nation-MFN-Policy-and-its-Impact-on-Biosimilars
18 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250717236374/en/Harrow-Enters-into-Commercialization-Agreement-with-Samsung-Bioepis-for-Ophthalmology-Biosimilars-Portfolio-in-the-United-States
14 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250710186470/en/Samsung-Bioepis-European-Whitepaper-Proposes-Solutions-to-Bridge-Policy-Gaps-that-Hinder-Healthy-Market-Competition-and-Timely-Access-to-Biosimilar-Medicines
12 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250611832264/en/Samsung-Bioepis-Presents-Long-Term-Safety-Data-of-EPYSQLI-Eculizumab-in-PNH-at-the-European-Hematology-Association-EHA-Congress-2025
09 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250608582351/en/Samsung-Bioepis-Enters-into-a-Strategic-Partnership-with-NIPRO-for-Commercialization-of-Multiple-Biosimilars-in-Japan
ABOUT THIS PAGE